A selective proteinase activated receptor-4 (PAR4) antagonist that inhibits endostatin release and platelet aggregation induced by thrombin.
CAT No: R0887
CAS No: 327177-34-4
Synonyms/Alias: TCY-NH2;327177-34-4;(trans-Cinnamoyl)-YPGKF-NH2;(2S)-N-[2-[[(2S)-6-amino-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1-oxohexan-2-yl]amino]-2-oxoethyl]-1-[(2S)-3-(4-hydroxyphenyl)-2-[[(E)-3-phenylprop-2-enoyl]amino]propanoyl]pyrrolidine-2-carboxamide;YPGKF;SCHEMBL5058350;HY-P1263;AKOS024456632;DA-68010;CS-0029155;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C40H49N7O7 |
M.W/Mr. | 739.9 |
Sequence | One Letter Code:YPGKF Three Letter Code:cinnamoyl(E)-Tyr-Pro-Gly-Lys-Phe-NH2 |
Labeling Target | Proteinase-activated receptor 4 (PAR4) |
Purity | >99% |
Activity | Antagonist |
Solubility | -20 °C |
InChI | InChI=1S/C40H49N7O7/c41-22-8-7-14-31(38(52)46-32(37(42)51)24-28-12-5-2-6-13-28)44-36(50)26-43-39(53)34-15-9-23-47(34)40(54)33(25-29-16-19-30(48)20-17-29)45-35(49)21-18-27-10-3-1-4-11-27/h1-6,10-13,16-21,31-34,48H,7-9,14-15,22-26,41H2,(H2,42,51)(H,43,53)(H,44,50)(H,45,49)(H,46,52)/b21-18+/t31-,32-,33-,34-/m0/s1 |
InChI Key | XKRAKQXQVIGYQC-PHOSSJRVSA-N |
Isomeric SMILES | C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)/C=C/C3=CC=CC=C3)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N |
BoilingPoint | N/A |
Melting Point | N/A |
1. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
5. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.